[Determination of salbutamol in human plasma by column-switching HPLC with UV detection]. 2003

Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
Department of Clinical Pharmacology, West China Hospital, Sichuan University, Chengdu 610041, China.

OBJECTIVE To make better the RP-HPLC method with column-switching technique for the determination of salbutamol in human plasma. METHODS A high-pressure flow channel selection valve and Kromasil C18 pretreatment column (20 x 4 mm, 5 microns), Ultrasphere Cyano analysis column (250 mm x 4.6 mm, 5 um, Beckman) were used. To the plasma sample 1.0 ml, 0.5 ml phosphate buffer (2.0 mol/L, pH 9.0) containing 0.4% diphenylboric acid 2-aminoethyl ester was added, then extraction was performed with the use of 4.0 ml chloroform containing 1% tetraoctylammonium bromide. The organic layer was removed and extracted again with 300 microliters (0.08 mol/L) acetic acid. 100 microliters of the acid layer was injected onto the column. The mobile phase of pH 2.8, 0.025 mol/L phosphate buffer-acetonitrile-methanol (95:4:1) was pumped at the rate of 0.9 and 1.0 ml.min-1 through the pretreatment and analysis column, respectively. The column-switching time was from 0.7 min to 1.5 min. The detector at 0.002 aufs was set at 224 nm. RESULTS The retention time for salbutamol was 6.7 min and that for internal standard (morphine) 7.6 min. The standard curve was linear over the concentration range from 0.5 to 32 micrograms/L. The lowest concentration of detection in plasma was 0.5 microgram/L. The method recovery was 96%-107%; the intra-day RSD less than 5%; the inter-day RSD less than 8%. CONCLUSIONS This method was found to be simple, rapid, sensitive and accurate for determination of salbutamol in human plasma.

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D000420 Albuterol A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. Salbutamol,2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol,Albuterol Sulfate,Proventil,Sultanol,Ventolin

Related Publications

Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
December 2003, Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan,
Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
January 1989, Biomedical chromatography : BMC,
Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
December 1994, Archives of pharmacal research,
Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
January 1997, Chirality,
Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
September 1999, Journal of pharmaceutical and biomedical analysis,
Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
April 2005, Therapeutic drug monitoring,
Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
October 2004, Biomedical chromatography : BMC,
Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
October 2000, Journal of pharmaceutical and biomedical analysis,
Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
May 2007, Biomedical chromatography : BMC,
Yongping Qin, and Yuangao Zou, and Maozhi Liang, and Qin Yu, and Ying Huang, and Tongling Li, and Xiaohong Xu
January 2007, Talanta,
Copied contents to your clipboard!